Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

431742

	registered interest
	date	23/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Per Capita Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much NHS England spent per head on mental health in each year since 2008.
	tabling member constituency	Central Suffolk and North Ipswich
	tabling member printed	Dr Poulter
	uin	17404
	answer	answer is ministerial correction date of answer 26/11/2015 answer text <p>NHS England was formed in April 2013.</p><br /><p>The table below shows actual expenditure by clinical commissioning groups (CCGs) on mental health in 2013/14 and 2014/15 and forecast spend in 2015/16. This does not include spending on mental health services directly commissioned by NHS England.</p><p>Total actual expenditure by on mental health by CCGs across all providers for 2013/14 and 2014/15 and the total forecast expenditure for 2015/16</p><br /><table><tbody><tr><td><p>2013/14 actual spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td><td><p>2014/15 actual spend (£ <ins class="ministerial">billion</ins><del class="ministerial">million</del>)</p></td><td><p>2015/16 forecast spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td></tr><tr><td><p>9.6</p></td><td><p>10.1</p></td><td><p>10.6</p></td></tr></tbody></table><br /><p><em>Source:</em> NHS England</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 26/11/2015 16:25:03 question first ministerially corrected 02/12/2015 14:16:07 answering member 4020 label Biography information for George Freeman previous answer version 32352 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	3932 label Biography information for Dr Dan Poulter

522126

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the Medicines and Healthcare Products Regulatory Agency holds any clinical trial data for HPV vaccines which is not in the public domain.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	38833
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>There are <del class="ministerial">two</del> <ins class="ministerial">three </ins>human papilloma virus vaccines licensed in the European Union: Cervarix<ins class="ministerial">,</ins> <del class="ministerial">and</del> <ins class="ministerial">Gardasil and </ins>Gardasil 9. These products are licensed centrally throughout Europe by the European Commission via the European Medicines Agency (EMA). Applicants for centrally authorised products are required to submit all relevant supporting clinical trials data, whether published or not, to the EMA directly and not to the Medicines and Healthcare products Regulatory Agency.</p><p> </p><p>Under current medicines legislation, the EMA database registers all EU-approved clinical trials of investigational medicinal products. Since March 2011 this information has been publicly accessible through the EU Clinical Trials Register (except adult Phase 1 trials). The EU Clinical Trials Register includes all EU-conducted trials since May 2004 when the Clinical Trials Directive was implemented and can be found here:</p><p> </p><p><a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">https://www.clinicaltrialsregister.eu/ctr-search/search</a></p><p> </p><p>Furthermore since July 2014 clinical trial sponsors have been required to provide a summary of their trial results uploaded onto the EU Clinical Trials Register within one year of their trial completing. There is a two year programme of back-loading underway to provide summaries of trial results for all trials on the Register back to when the EudraCT database was initiated in May 2004.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/06/2016 10:57:37 question first ministerially corrected 13/06/2016 10:14:27 answering member 4020 label Biography information for George Freeman previous answer version 2228 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

428805

	registered interest
	date	17/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Devon
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of progress in the urgent and emergency care vanguard run by South Devon and Torbay System Resilience Group.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	16731
	answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>In July, NHS England and the NHS Five Year Forward View partners announced eight urgent and emergency care vanguards. This included the South Devon and Torbay System Resilience Group.</p><br /><p>The new care models programme team visited the vanguard on 21 October 2015. This was an opportunity for the new care models programme team and vanguard team to jointly explore the vanguard’s proposals in more detail and to better understand the challenges they may face in delivering them.</p><br /><p>As the vanguard is still in its mobilisation phase, the new care models team cannot, at this stage, comment in detail on progress. However, from visits and assessments carried out to date, the new care models programme team has stated that it is clear that the vanguard has ambitious plans, a clear vision and is moving at pace. This will enable it to establish the infrastructure required to deliver new models of care effectively, building on existing local relationships and structures and good practice.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:22:26 answering member 4020 label Biography information for George Freeman
	tabling member	4249 label Biography information for Anne Marie Morris

428807

	registered interest
	date	17/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Rural Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether there are any vanguards in rural areas.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	16733
	answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>There are now 50 vanguards across England, the majority of which are in localities that span both rural and urban areas. These include Dorset, Northumbria, Cheshire, Hertfordshire, Hampshire, Somerset, Cambridgeshire, Leicestershire, West Yorkshire and Devon.</p><br /><p><strong></strong></p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:25:04 answering member 4020 label Biography information for George Freeman
	tabling member	4249 label Biography information for Anne Marie Morris

429092

	registered interest
	date	18/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Rural Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will change the criteria for primary and acute care provision better benefit rural communities.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	16754
	answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>All new care model vanguards, which include multispecialty community providers, integrated primary and acute care systems, enhanced health in care homes, urgent and emergency care and acute care collaborations have now been selected.</p><br /><p>Selection of the 50 vanguards followed an open and rigorous process, with participating organizations being selected from urban and rural areas.</p><br /><p>While NHS England is only able to have a limited number of vanguards as part of its national programme, it aims to support all local areas with an ambition to deliver care in new ways that improve patient experience and outcomes.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 16755 question first answered 01/12/2015 16:42:44 answering member 4020 label Biography information for George Freeman
	tabling member	4249 label Biography information for Anne Marie Morris

429093

	registered interest
	date	18/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Community Care: Rural Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will change the criteria for multi-specialty community providers better to benefit rural areas.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	16755
	answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>All new care model vanguards, which include multispecialty community providers, integrated primary and acute care systems, enhanced health in care homes, urgent and emergency care and acute care collaborations have now been selected.</p><br /><p>Selection of the 50 vanguards followed an open and rigorous process, with participating organizations being selected from urban and rural areas.</p><br /><p>While NHS England is only able to have a limited number of vanguards as part of its national programme, it aims to support all local areas with an ambition to deliver care in new ways that improve patient experience and outcomes.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 16754 question first answered 01/12/2015 16:42:44 answering member 4020 label Biography information for George Freeman
	tabling member	4249 label Biography information for Anne Marie Morris

431390

	registered interest
	date	20/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department made of the effect of the Innovation Health and Wealth report, published in December 2011, on innovation in the NHS.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	17109
	answer	answer is ministerial correction date of answer 30/11/2015 answer text <p>The Department is funding RAND Europe and the University of Manchester to conduct a formative and summative evaluation of Innovation, Health and Wealth. The project is expected to complete in 2017 and the report on the first stage of the evaluation is due to be published imminently. Further details can be found on the RAND Europe website:</p><br /><p><a href="http://www.rand.org/randeurope/research/projects/innovation-health-wealth.html" target="_blank">www.rand.org/randeurope/research/projects/innovation-health-wealth.html</a></p><br /><p>Since the publication of <em>Creating Change: Innovation, Health and Wealth one year on</em> in 2012, there has been a great deal of progress made in many of the IHW work streams. Much of this has been incorporated into NHS England’s <em>Innovation Into Action: Supporting delivery of the NHS Five Year Funding View</em>, published in September 2015 and can be found at:</p><br /><p><a href="http://www.england.nhs.uk/wp-content/uploads/2015/10/nhs-inovation-into-action.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2015/10/nhs-inovation-into-action.pdf</a></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 30/11/2015 17:21:51 answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

431391

	registered interest
	date	20/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Department of Health: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what effect the sunset review of NHS and his Department funded or sponsored innovation bodies, set out in the Innovation, Health and Wealth report, published in December 2011, had on the form, funding and effectiveness of such bodies.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	17110
	answer	answer is ministerial correction date of answer 30/11/2015 answer text <p>The sunset review of innovation and improvement bodies was an internal review which helped shape long term plans for a number of organisations, including the 15 academic health science networks.</p><br /><p>The Department is funding RAND Europe and the University of Manchester to conduct a formative and summative evaluation of Innovation, Health and Wealth. The project is expected to complete in 2017, the report on the first stage of the evaluation is due to be published imminently. Further details can be found on the RAND Europe website:</p><br /><p><a href="http://www.rand.org/randeurope/research/projects/innovation-health-wealth.html" target="_blank">www.rand.org/randeurope/research/projects/innovation-health-wealth.html</a></p><br /><p>Since the publication of One Year On in 2012, an update on the implementation of the Innovation Health and Wealth (IHW) report, there has been a great deal of progress made in many of the IHW work streams. Much of this has been incorporated into NHS England’s Innovation Into Action: Supporting delivery of the NHS Five Year Funding View, published in September 2015 and can be found at:</p><br /><p><a href="https://www.england.nhs.uk/wp-content/uploads/2015/10/nhs-inovation-into-action.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2015/10/nhs-inovation-into-action.pdf</a></p><br /> <br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 30/11/2015 17:33:59 answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

431394

	registered interest
	date	20/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cannabis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent clinical assessments his Department has made of the potential medical benefits of cannabis.
	tabling member constituency	Belfast East
	tabling member printed	Gavin Robinson
	uin	17135
	answer	answer is ministerial correction date of answer 30/11/2015 answer text <p>Cannabis and its preparations are Class B controlled drugs under the Misuse of Drugs Act 1971. Cannabis is also subject to international drug control under UN Conventions. In the United Kingdom, it is illegal to produce, possess, supply, import and export cannabis except under Home Office licence. Apart from the drug Sativex, which is derived from cannabis, the UK does not recognise herbal cannabis as having any medicinal use.</p><br /><p>The National Institute for Health and Care Excellence (NICE) published a clinical guideline on the management of multiple sclerosis in October 2014 that does not recommend Sativex, a cannabis-derived treatment, as a cost effective use of National Health Service resources. NICE’s guideline on multiple sclerosis is published at:</p><br /><p><a href="https://www.nice.org.uk/guidance/cg186/resources/multiple-sclerosis-management-of-multiple-sclerosis-in-primary-and-secondary-care-35109816059077" target="_blank">https://www.nice.org.uk/guidance/cg186/resources/multiple-sclerosis-management-of-multiple-sclerosis-in-primary-and-secondary-care-35109816059077</a></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 30/11/2015 17:23:35 answering member 4020 label Biography information for George Freeman
	tabling member	4360 label Biography information for Gavin Robinson

431696

	registered interest
	date	23/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research his Department has conducted on the disincentives to prescribing off-patent repurposed drugs.
	tabling member constituency	Glasgow North West
	tabling member printed	Carol Monaghan
	uin	17150
	answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The Department has conducted no such research. Current arrangements already allow off-patent drugs to be prescribed for new purposes where this is the most appropriate clinical treatment course for a patient. Prescribing decisions are a matter for the clinical judgement of the prescriber concerned.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:49:32 answering member 4020 label Biography information for George Freeman
	tabling member	4443 label Biography information for Carol Monaghan